Daniel Ardeljan, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Long Interspersed Nucleotide Elements | 3 | 2020 | 330 | 1.230 |
Why?
|
| Macular Degeneration | 3 | 2014 | 1007 | 0.790 |
Why?
|
| Retroelements | 3 | 2021 | 163 | 0.690 |
Why?
|
| Interleukin-17 | 2 | 2014 | 912 | 0.590 |
Why?
|
| Receptors, Interleukin-17 | 1 | 2014 | 82 | 0.450 |
Why?
|
| Wet Macular Degeneration | 2 | 2013 | 162 | 0.450 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2013 | 34 | 0.430 |
Why?
|
| Synapsins | 1 | 2013 | 43 | 0.430 |
Why?
|
| Geographic Atrophy | 1 | 2013 | 91 | 0.400 |
Why?
|
| Alu Elements | 2 | 2019 | 115 | 0.290 |
Why?
|
| Transfection | 1 | 2014 | 5774 | 0.260 |
Why?
|
| DNA | 1 | 2020 | 7212 | 0.260 |
Why?
|
| Neoplasms | 4 | 2020 | 22170 | 0.260 |
Why?
|
| Retina | 1 | 2014 | 2659 | 0.210 |
Why?
|
| Cytokines | 1 | 2014 | 7396 | 0.160 |
Why?
|
| Macrophages | 1 | 2014 | 5769 | 0.160 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2017 | 15936 | 0.140 |
Why?
|
| RNA Splicing | 2 | 2019 | 918 | 0.140 |
Why?
|
| DNA Transposable Elements | 1 | 2019 | 755 | 0.120 |
Why?
|
| Phenotype | 1 | 2013 | 16591 | 0.120 |
Why?
|
| Gene Rearrangement | 1 | 2020 | 1125 | 0.120 |
Why?
|
| Aging | 1 | 2013 | 8708 | 0.120 |
Why?
|
| Retinitis | 1 | 2014 | 36 | 0.110 |
Why?
|
| HeLa Cells | 1 | 2020 | 3093 | 0.110 |
Why?
|
| Bruch Membrane | 1 | 2013 | 65 | 0.110 |
Why?
|
| Retinal Drusen | 1 | 2013 | 74 | 0.110 |
Why?
|
| DNA Replication | 1 | 2020 | 1418 | 0.100 |
Why?
|
| Autoantibodies | 1 | 2021 | 2116 | 0.100 |
Why?
|
| Phospholipases A2 | 1 | 2012 | 197 | 0.100 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2013 | 209 | 0.100 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2013 | 122 | 0.100 |
Why?
|
| Disease | 1 | 2017 | 672 | 0.100 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2020 | 0.090 |
Why?
|
| Genetic Markers | 1 | 2017 | 2601 | 0.090 |
Why?
|
| Quantitative Trait Loci | 1 | 2019 | 2116 | 0.090 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4278 | 0.090 |
Why?
|
| Eye Proteins | 1 | 2013 | 633 | 0.080 |
Why?
|
| Genetic Loci | 1 | 2019 | 2632 | 0.080 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2020 | 2917 | 0.080 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2021 | 2155 | 0.080 |
Why?
|
| Dependovirus | 1 | 2014 | 718 | 0.080 |
Why?
|
| Retinal Degeneration | 1 | 2012 | 413 | 0.080 |
Why?
|
| Genome, Human | 1 | 2020 | 4425 | 0.070 |
Why?
|
| Heterozygote | 1 | 2013 | 2787 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 7594 | 0.060 |
Why?
|
| Software | 1 | 2019 | 4434 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2013 | 1902 | 0.060 |
Why?
|
| Genetic Vectors | 1 | 2014 | 3395 | 0.060 |
Why?
|
| Cell Proliferation | 1 | 2020 | 10445 | 0.060 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 8547 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 16981 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2019 | 12795 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2013 | 3113 | 0.050 |
Why?
|
| Humans | 13 | 2021 | 761504 | 0.050 |
Why?
|
| Case-Control Studies | 3 | 2017 | 22176 | 0.050 |
Why?
|
| RNA-Directed DNA Polymerase | 1 | 2021 | 225 | 0.050 |
Why?
|
| Granzymes | 1 | 2021 | 277 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2021 | 343 | 0.040 |
Why?
|
| Cell Line | 1 | 2013 | 15601 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 18252 | 0.040 |
Why?
|
| Interferons | 1 | 2021 | 706 | 0.040 |
Why?
|
| RNA Splice Sites | 1 | 2019 | 211 | 0.040 |
Why?
|
| Autoantigens | 1 | 2021 | 891 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2020 | 23445 | 0.030 |
Why?
|
| Introns | 1 | 2019 | 981 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2017 | 17904 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 2019 | 1093 | 0.030 |
Why?
|
| Exons | 1 | 2019 | 2391 | 0.030 |
Why?
|
| Linkage Disequilibrium | 1 | 2017 | 1998 | 0.020 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2012 | 161 | 0.020 |
Why?
|
| RNA | 1 | 2021 | 2726 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2013 | 58976 | 0.020 |
Why?
|
| Mice | 2 | 2019 | 81525 | 0.020 |
Why?
|
| Chemokine CCL2 | 1 | 2012 | 605 | 0.020 |
Why?
|
| Drosophila melanogaster | 1 | 2019 | 1712 | 0.020 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2019 | 1469 | 0.020 |
Why?
|
| Genetic Variation | 1 | 2019 | 6567 | 0.010 |
Why?
|
| Aged | 2 | 2013 | 169289 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2012 | 2672 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2012 | 3492 | 0.010 |
Why?
|
| Alleles | 1 | 2012 | 6863 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 220895 | 0.010 |
Why?
|
| Genotype | 1 | 2012 | 12990 | 0.010 |
Why?
|
| Male | 2 | 2013 | 360804 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2017 | 12690 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2012 | 14414 | 0.010 |
Why?
|
| Female | 2 | 2013 | 392644 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2012 | 22169 | 0.010 |
Why?
|
| Animals | 2 | 2019 | 168459 | 0.010 |
Why?
|
| Prognosis | 1 | 2012 | 29625 | 0.010 |
Why?
|